CLOSE| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 15, 2024 |
Director, President & CEO
Trans History: 126
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 84,270 | -- | 803,704 |
| Feb 15, 2024 |
Chief Innovation Officer
Trans History: 50
|
Chief Innovation Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 37,921 | -- | 246,228 |
| Feb 15, 2024 |
Chief Operating Officer
Trans History: 24
|
Chief Operating Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 37,921 | -- | 215,616 |
| Dec 06, 2023 |
EVP & Chief Financial Officer
Trans History: 153
|
EVP & Chief Financial Officer | Form 4 | Bona fide gift | 715 | -- | 325,171 |
| Nov 28, 2023 |
EVP,General Counsel, Secretary
Trans History: 39
|
EVP,General Counsel, Secretary | Form 4 | Bona fide gift | 4,000 | -- | 177,817 |
| Mar 20, 2023 |
EVP, Chief Development Officer
Trans History: 186
|
EVP, Chief Development Officer | Form 4 | Other acquisition or disposition (describe transaction) | 6,778 | -- | 200,472 |
| Feb 21, 2023 |
EVP,General Counsel, Secretary
Trans History: 39
|
EVP,General Counsel, Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 27,293 | -- | 262,314 |
| Feb 21, 2023 |
Chief Human Resources
Trans History: 16
|
Chief Human Resources | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,224 | -- | 257,773 |
| Feb 21, 2023 |
EVP & Chief Financial Officer
Trans History: 153
|
EVP & Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 27,293 | -- | 394,253 |
| Feb 21, 2023 |
EVP, Chief Development Officer
Trans History: 186
|
EVP, Chief Development Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 27,293 | -- | 230,363 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.